| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/07/2011 | CN102174546A Phospholipases, nucleic acids encoding them and methods for making and using them |
| 09/07/2011 | CN102174541A Method for modifying plant morphology, biochemistry and physiology |
| 09/07/2011 | CN102174540A Method for modifying plant morphology, biochemistry and physiology |
| 09/07/2011 | CN102174534A S. pneumoniae antigens |
| 09/07/2011 | CN102174533A Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 09/07/2011 | CN102174475A Preparation and application of hIL-17RD-ECD monoclonal antibody |
| 09/07/2011 | CN102174474A Sildenafil monoclonal antibody and colloidal gold chromatography test strip used for detecting sildenafil |
| 09/07/2011 | CN102174108A Internalizing anti-cd74 antibodies and methods of use |
| 09/07/2011 | CN102174107A Monoclonal antibody for plague bacillus Pla (plasminogen activator) and application thereof |
| 09/07/2011 | CN102174106A Anti-Met humanized Fab, anti-Met humanized Fab and doxorubicin conjugate and preparation method and application of anti-Met humanized Fab and doxorubicin conjugate |
| 09/07/2011 | CN102174105A Antibodies directed to her-3 and uses thereof |
| 09/07/2011 | CN102174104A Duck plague virus cyst membrane gI protein polyclonal antibody as well as preparation method and application thereof |
| 09/07/2011 | CN102172403A Method for treating interleukin-6 related diseases |
| 09/07/2011 | CN102172400A Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 09/07/2011 | CN102172398A Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins |
| 09/07/2011 | CN101643509B VEGFR-2 resistant monoclonal antibody with human and mouse cross reaction as well as preparation method and application thereof |
| 09/07/2011 | CN101429243B Melamine and carrier protein couplet product, preparation method and uses of melamine antibody |
| 09/07/2011 | CN101407546B Human anti-human tumor necrosis factor-alpha single chain antibody |
| 09/07/2011 | CN101278060B Gene galnt6 as breast cancer marker and small interfering RNAS directed against gene GALNT6 |
| 09/07/2011 | CN101230103B Human recombinant anti-IgE antibody |
| 09/07/2011 | CN101066998B Prepn of specific antibody of provera acetate and method of using the antibody in homogenous or heterogenous enzyme-linked immune analysis |
| 09/06/2011 | US8013208 Methods for producing antibodies |
| 09/06/2011 | US8013135 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| 09/06/2011 | US8013128 Antibodies and related molecules that bind to PSCA proteins |
| 09/06/2011 | US8013127 Antibody that binds to ER-α36 |
| 09/06/2011 | US8013126 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer |
| 09/06/2011 | US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines |
| 09/06/2011 | US8013123 Use of precursors of enkephalins and/or their fragments in medical diagnostics |
| 09/06/2011 | US8013118 Lynx polypeptides |
| 09/06/2011 | US8013113 FRET protease assays for clostridial toxins |
| 09/06/2011 | US8013112 Compositions comprising human brain natriuretic peptide (BNP) fragments |
| 09/06/2011 | US8012945 Single chain fragment variable (scFv) antibody or an Fab antibody; screening phage-displayed antibodies for an ability to bind to a radiation-inducible neoantigen present on a cell |
| 09/06/2011 | US8012932 Contraceptives based on SP22 and SP22 antibodies |
| 09/06/2011 | US8012754 Antibody compositions |
| 09/06/2011 | US8012748 Peripheral nervous system specific sodium channel nucleic acids |
| 09/06/2011 | US8012707 MN gene and protein |
| 09/06/2011 | US8012704 Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use |
| 09/06/2011 | US8012697 Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma |
| 09/06/2011 | US8012694 Assay for the detection of phosphorylated PTH |
| 09/06/2011 | US8012485 Drug conjugate composition |
| 09/06/2011 | US8012484 Using immunoglobulins which inhibit natural killer cell activity as therapeutic agents in prevention and treatment of ischemic injury; antitumor agents; adenosine receptor agonist |
| 09/06/2011 | US8012483 Phosphorylcholine conjugates and corresponding antibodies |
| 09/06/2011 | US8012482 Humanized anti-TGF-beta antibodies |
| 09/06/2011 | US8012476 Molecules with extended half-lives, compositions and uses thereof |
| 09/06/2011 | US8012475 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases |
| 09/06/2011 | US8012474 Anti-RANTES antibodies |
| 09/06/2011 | US8012473 C3b antibodies and methods for the prevention and treatment of complement-associated disorders |
| 09/06/2011 | US8012470 Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies |
| 09/06/2011 | CA2463085C Vaccines against arthropod-borne infectious diseases |
| 09/06/2011 | CA2452260C Novel variants and exons of the glyt1 transporter |
| 09/04/2011 | CA2695337A1 Compositions and methods for inhibition of hiv |
| 09/01/2011 | WO2011106723A2 Anti-paf antibodies |
| 09/01/2011 | WO2011106528A1 Folate receptor 1 antibodies and immunoconjugates and uses thereof |
| 09/01/2011 | WO2011106401A2 Methods and compositions relating to multiciliate cell differentiation |
| 09/01/2011 | WO2011106300A2 Anti-angiogenesis therapy for the treatment of ovarian cancer |
| 09/01/2011 | WO2011106297A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/01/2011 | WO2011105573A1 Anti-icam3 antibody and use thereof |
| 09/01/2011 | WO2011105544A1 Tumor marker, antibody to same, detection kit for same, and method for detecting same |
| 09/01/2011 | WO2011105424A1 Dendritic cell immunoreceptor stimulant |
| 09/01/2011 | WO2011104696A1 Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies |
| 09/01/2011 | WO2011104687A1 Antagonist anti-il-7 receptor antibodies and methods |
| 09/01/2011 | WO2011104604A2 Anti-alpha2 integrin antibodies and their uses |
| 09/01/2011 | WO2011104565A1 Camelid antibodies for use in compositions and methods for the treatment of cancer |
| 09/01/2011 | WO2011104558A1 Cancer vaccine |
| 09/01/2011 | WO2011104315A2 Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 09/01/2011 | WO2011104307A2 Ligands for antibody purification by affinity chromatography |
| 09/01/2011 | WO2011103702A1 Fully human monoclonal antibody to vegf, preparation method and use thereof |
| 09/01/2011 | WO2011103701A1 Full human anti-tnf- alpha monoclonal antibody, preparation method and use thereof |
| 09/01/2011 | WO2011103700A1 Fully humanized anti-her2 antibody, preparation method and use thereof |
| 09/01/2011 | WO2011103667A1 Agonistic antibodies to trkb receptors and uses thereof |
| 09/01/2011 | US20110214193 Biomarker for microdomain disease |
| 09/01/2011 | US20110213130 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 09/01/2011 | US20110213129 Diagnostics and treatments of periodontal disease |
| 09/01/2011 | US20110213128 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 09/01/2011 | US20110213127 Methods for using and identifying modulators of delta-like 4 |
| 09/01/2011 | US20110213125 Humanized Antibodies Against Human Interferon-Alpha |
| 09/01/2011 | US20110212895 Treatment of Cognitive and Learning Impairment |
| 09/01/2011 | US20110212859 Radio frequency identifiers for use in biological science |
| 09/01/2011 | US20110212518 Expression vector and methods of producing high levels of proteins |
| 09/01/2011 | US20110212471 Method for diagnosing atherosclerotic plaques by measurement of cd36 |
| 09/01/2011 | US20110212470 Biomarkers for rheumatoid arthritis |
| 09/01/2011 | US20110212449 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 09/01/2011 | US20110212133 Novel Methods of Diagnosis and Treatment of P. Aeruginosa Infection and Reagents Therefor |
| 09/01/2011 | US20110212116 Immunogenic peptides and uses thereof |
| 09/01/2011 | US20110212114 Method for making targeted therapeutic agents |
| 09/01/2011 | US20110212113 Monoclonal Antibody SC104 and Derivative Thereof Specifically Binding to a Sialyltetraosyl Carbohydrate as a Potential Anti-Tumor Therapeutic Agent |
| 09/01/2011 | US20110212112 Conformation specific antibodies |
| 09/01/2011 | US20110212110 Compositions and Methods for Detecting TLR3 |
| 09/01/2011 | US20110212109 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES |
| 09/01/2011 | US20110212106 Hiv-1 neutralizing antibodies and uses thereof |
| 09/01/2011 | US20110212104 Inflammatory bowel disease biomarkers and related methods of treatment |
| 09/01/2011 | US20110212098 Novel Melanoma Antigen Peptide and Uses Thereof |
| 09/01/2011 | US20110212096 Anti-p-selectin antibodies and methods of their use and identification |
| 09/01/2011 | US20110212095 Epitope of cd66c specific to lung adenocarcinoma and antibody recognizing the same |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212092 Glucagon receptor antagonists |
| 09/01/2011 | US20110212091 Materials and methods for inhibiting cancer cell invasion |
| 09/01/2011 | US20110212088 Anti-paf antibodies |
| 09/01/2011 | US20110212087 Antibody Fc Mutants with Ablated Effector Functions |
| 09/01/2011 | US20110212085 Lung cancer disease targets and uses thereof |